Retrospective evaluation of the effectiveness of using two different products in preventing the development of pressure injuries in patients undergoing lung lobectomy

dc.authorwosidLukovnikova, Anna A/J-3296-2018
dc.contributor.authorIsikli, Ayse Gokce
dc.contributor.authorOzkan, Zeynep Kizilcik
dc.date.accessioned2024-06-12T10:54:12Z
dc.date.available2024-06-12T10:54:12Z
dc.date.issued2023
dc.departmentTrakya Üniversitesien_US
dc.description.abstractAim: This retrospective study aims to determine the impacts of two different products (barrier cream, barrier spray) routinely used before surgery on the development of postoperative pressure injuries in patients under-going lung lobectomy. Materials and methods: In the study, the researchers retrospectively examined the data of 60 patients who un-derwent lobectomy in a university hospital's thoracic surgery clinic between 12.02.2021 and 14.02.2022. The patients were divided into two groups: those to whom a barrier cream was applied (30) and those to whom a barrier spray was applied. The Patient Description Form and the Braden Risk Assessment Tool were used in data collection. The Mann-Whitney U and Kruskal-Wallis tests were conducted for statistical analyses. Results: In the study, the development rates of blanchable erythema and stage I pressure injuries in the sacral and dorsal regions were significantly higher in patients to whom a barrier spray was applied than in patients to whom a barrier cream was applied (p < 0.05). Pain intensity in the sacral and dorsal regions was significantly lower in patients to whom a barrier cream was applied than those to whom a barrier spray was applied (p < 0.05). Conclusion: Blanchable erythema and intraoperative pressure injury were observed less in patients in whom a barrier cream was used before surgery. Surgical nurses should first evaluate the risk in the preoperative period in the clinics and benefit from the use of barrier cream to prevent the development of blanchable erythema and intraoperative pressure injury.en_US
dc.identifier.doi10.1016/j.jtv.2022.10.003
dc.identifier.endpage167en_US
dc.identifier.issn0965-206X
dc.identifier.issn1876-4746
dc.identifier.issue1en_US
dc.identifier.pmid36351868en_US
dc.identifier.scopus2-s2.0-85143525050en_US
dc.identifier.scopusqualityQ2en_US
dc.identifier.startpage163en_US
dc.identifier.urihttps://doi.org/10.1016/j.jtv.2022.10.003
dc.identifier.urihttps://hdl.handle.net/20.500.14551/18968
dc.identifier.volume32en_US
dc.identifier.wosWOS:000953365300001en_US
dc.identifier.wosqualityN/Aen_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakScopusen_US
dc.indekslendigikaynakPubMeden_US
dc.language.isoenen_US
dc.publisherElsevier Sci Ltden_US
dc.relation.ispartofJournal Of Tissue Viabilityen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectBarrier Creamen_US
dc.subjectBarrier Sprayen_US
dc.subjectNursing Careen_US
dc.subjectPressure Injuryen_US
dc.subjectThoracic Surgeryen_US
dc.subjectBarrier Creamen_US
dc.subjectRisk-Factorsen_US
dc.subjectSkinen_US
dc.subjectUlcersen_US
dc.subjectCareen_US
dc.titleRetrospective evaluation of the effectiveness of using two different products in preventing the development of pressure injuries in patients undergoing lung lobectomyen_US
dc.typeArticleen_US

Dosyalar